• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Safety

  • Print
  • Share
  • E-mail
?
-

Resources for You

Famvir (famciclovir) Tablets 125, 250, 500 mg December 2008

Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER) -- December 2008

 

The detailed view includes drug products with safety labeling changes to the BOXED WARNING, CONTRAINDICATIONS, WARNINGS, PRECAUTIONS, ADVERSE REACTIONS, or PATIENT PACKAGE INSERT/MEDICATION GUIDE sections. Deletions or editorial revisions made to these sections are not included in this summary. Read about the new physician labeling format.


 

Summary View

Sections Modified

PRECAUTIONS

  • Drug Interactions
  • Pregnancy Exposure Registry
  • Nursing Mothers

ADVERSE REACTIONS

  • Post Marketing Experience
    • .........SJS, TEN, cholestatic jaundice, abnormal LFTs....